Astrana Health Inc. · NASDAQ
Sign up free to see this.
Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
No sentiment yet
At least 5 tagged posts are needed.
How do you feel about ASTH?
Zacks Investment Research
Why Astrana Health, Inc. (ASTH) is Poised to Beat Earnings Estimates AgainAstrana Health (ASTH) is expected to beat earnings estimates again based on its strong track record of earnings surprises. The company has averaged a 92.10% surprise rate over the last two quarters, with a +12.78% Earnings ESP and Zacks Rank #3 (Hold), suggesting another potential beat is likely.
GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc. - ASTHPomerantz LLP is investigating potential securities fraud claims against Astrana Health, Inc. following a Glass House Research short report alleging aggressive acquisitions, subjective management estimates, concerns over a $545 million related-party loan, and 2027 Medicare regulatory exposure. The stock fell 9.02% to $34.30 per share on September 17, 2026.
Headlines link to the publisher. Not investment advice.
No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.
Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
No sentiment yet
Sign in to post on $ASTH
No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.
